News Cordis Acquires MedAlliance for $1.13 Billion, Expanding Medical Technology Reach Switzerland-based MedAlliance, acclaimed for its revolutionary Drug-Eluting Balloon technology, has been acquired by Cordis in a significant $1.13 billion deal.
